AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (8.6 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Systematic Review | Open Access | Online First

Efficacy and safety of American ginseng-based therapies for cancer: a systematic review and meta-analysis

Yuan Liu1,§, Ting-xiu Liu1,§, Yu Du2, Kai Liu1, Yi-ke Song1, Zi-yi Li3, Shi-yun Shi3, Zhao-lan Liu1( )
Center for Evidence-Based Medicine, Beijing University of Chinese Medicine, 100029, Beijing, China
Business Analytics, University of Colorado Denver, Denver, 80202, USA
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China

§These authors contributed equally to this work.

Show Author Information

Abstract

Introduction

To systematically evaluate the efficacy and safety of American ginseng (AG, Panax quinquefolius L.)-based cancer therapies and assess the certainty of the available evidence.

Methods

We searched the China National Knowledge Infrastructure, Wanfang, Chinese Scientific Journals Database, SinoMed, PubMed, Embase, and the Cochrane Library databases from inception until December 8, 2025, and updated the search through June 30, 2026, for randomized controlled trials (RCTs) evaluating AG-based therapies for malignant tumors. Two reviewers independently selected studies, extracted data, assessed risk of bias using the Cochrane Risk of Bias 2 tool, and assessed evidence certainty using the Grading of Recommendations Assessment, Development and Evaluation (GRADE)pro guideline development tool. Disagreements were resolved by consultation with a third reviewer. Meta-analyses, data visualization, and sensitivity analyses were performed using R software.

Results

The meta-analysis included 15 RCTs involving 1415 participants (intervention group: 857 participants; control group: 558 participants). Pooled analyses of traditional Chinese medicine (TCM) formulations containing AG suggested a higher objective response rate (ORR) when combined with conventional medical treatment (CMT) (risk ratio [RR] = 1.39, 95% confidence interval [CI]: 1.04, 1.85) and a higher disease control rate (DCR) when administered alone or in combination with CMT (RR = 1.21, 95% CI: 1.10, 1.33). A higher proportion of patients receiving AG-containing TCM formulations met the study-defined criterion for improved Karnofsky Performance Status (KPS) (RR = 2.62, 95% CI: 1.63, 4.21). Pooled estimates also favored AG-containing TCM formulations plus CMT for chemotherapy-related leukopenia, gastrointestinal reactions, hepatic dysfunction, and alopecia, although several of these estimates were based on a small number of studies. The certainty of evidence across outcomes was low or very low.

Conclusion

Although several pooled estimates favored AG-containing TCM formulations, the certainty of the available evidence was low to very low certainty. Therefore, our findings should be considered exploratory rather than confirmatory.

Registration

This study was registered with the International Prospective Register of Systematic Reviews (https://www.crd.york.ac.uk/PROSPERO/, CRD420261419243).

Electronic Supplementary Material

Download File(s)
Appendix 1 Literature search strategies.xlsx (10.5 KB)
Appendix 2 Intervention details of included studies.docx (22.2 KB)
Appendix 3 Leave-one-out forest plots for tumor response outcomes, chemotherapy-related adverse events, and immune function outcomes.docx (6.8 MB)

References

【1】
【1】
 
 
Evidence-Based Chinese Medicine and Technology Assessment

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Liu Y, Liu T-x, Du Y, et al. Efficacy and safety of American ginseng-based therapies for cancer: a systematic review and meta-analysis. Evidence-Based Chinese Medicine and Technology Assessment, 2026, https://doi.org/10.26599/eCMTA.2026.9570048

20

Views

7

Downloads

0

Crossref

Received: 26 June 2026
Revised: 24 August 2026
Accepted: 04 September 2026
Published: 28 September 2026
© 2026 Beijing University of Chinese Medicine. Production and hosting by Tsinghua University Press.

This is an open access article under the CC-BY license (http://creativecommons.org/licenses/by/4.0/).